Myeloid and Mixed or Ambiguous Lineage Neoplasms

Datasets > Published Datasets > Haematolymphoid > Myeloid and Mixed or Ambiguous Lineage Neoplasms

Scope

The dataset has been developed for the pathology reporting of myeloid and mixed or ambiguous lineage haematopoietic neoplasms and applies to specimens from peripheral blood, bone marrow, lymph node, spleen, skin, central nervous system, or other anatomic sites. Histologic, immunophenotypic, and genetic findings are integrated to formulate the final diagnosis.

ICCR Myeloid and Mixed or Ambiguous Lineage Neoplasms Bookmarked guide - 7750 KB

Publication History

1st edition – September 2026

To reference this dataset please use the following citation: Chen X, Chen W, Daver N, Gujral S, Hochhaus A, Kvasnicka HM, Nardi V, Naresh K, Solary E, Sotlar K, Tzankov A, Au-Yeung RKH, Khoury J (2026). Myeloid and Mixed or Ambiguous Lineage Neoplasms Integrated Pathology Reporting Guide. 1st edition. International Collaboration on Cancer Reporting; Sydney, Australia. ISBN: 978-1-922324-86-3.

Expert Committee

The 1st edition of the dataset for Myeloid and mixed or ambiguous lineage neoplasms was developed by the following international team:

Chair – Xueyan Chen, USA
Series Champion – Joseph Khoury, USA
ICCR representative – Rex Au-Yeung, Hong Kong

Domain experts:

Weina Chen, USA
Naval Daver, USA
Sumeet Gujral, India
Andreas Hochhaus, Germany
Hans Michael Kvasnicka, Germany
Valentina Nardi, USA
Kikkeri Naresh, USA
Eric Solary, France
Karl Sotlar, Austria
Alexandar Tzankov, Switzerland

Myeloid and Mixed or Ambiguous Lineage Neoplasms

Scope

Publication History

Expert Committee

Contact